POLE c.1138G>T (p.Gly380Cys) (MAFgnomAD_NFE = 0.005%), predicted deleterious, was identified in a woman diagnosed with two synchronic breast tumors, and in an unrelated individual with multiple (10–20) adenomatous polyps and no familial cancer history. Here, POLE is linked to hereditary cancer.